Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03230188 · ClinicalTrials.gov registry record
Patterns of Neurocircuitry Activation In Severe Asthma
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 28
- Enrollment target
NCT03230188: Completed study, sponsored by University of Wisconsin, Madison.
NCT03230188 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 28 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03230188 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
The overall purpose of the study is to compare the patterns of neurocircuitry activation in severe asthmatics vs. mild to moderate and healthy controls. The Investigators hypothesize that neurocircuitry activation increases with asthma severity, producing different neurocircuitry patterns for severe asthmatics than those of mild to moderate asthmatics or non-asthmatics.
Primary Outcome
% signal change in brain insula detected by functional Magnetic Resonance Imaging
Interventions
- OTHER Cognitive Function Testing (non-diagnostic)
- OTHER Asthma and Psychological Questionnaires (non-diagnostic)
- OTHER functional Magnetic Resonance Imaging (research grade)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2018-06-17 |
What the finished NCT03230188 record still lists
NCT03230188 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 28 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which Cognitive Function Testing (non-diagnostic) is the first listed.
NCT03230188 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03230188 about?
NCT03230188 is a clinical study titled "Patterns of Neurocircuitry Activation In Severe Asthma". The overall purpose of the study is to compare the patterns of neurocircuitry activation in severe asthmatics vs. mild to moderate and healthy controls. The Investigators hypothesize that neurocircuitry activation increases with asthma severity, producing different neurocircuitry patterns for severe...
What is the current status of trial NCT03230188?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2017-08-01. Estimated completion is 2018-06-17.
What interventions are being tested in trial NCT03230188?
The interventions under investigation include: Cognitive Function Testing (non-diagnostic) (OTHER), Asthma and Psychological Questionnaires (non-diagnostic) (OTHER), functional Magnetic Resonance Imaging (research grade) (OTHER).
Who is sponsoring clinical trial NCT03230188?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI